• Nenhum resultado encontrado

Clinical Effectiveness - Cancer Care

N/A
N/A
Protected

Academic year: 2023

Share "Clinical Effectiveness - Cancer Care"

Copied!
1
0
0

Texto

(1)

Year Month N D J F M A M J J A S O N D J F M A M SS W P I PCCT CO

1 National => % 93.0 93.0 - Mar 2019 97.7 94.6 98.9 - 96.1 97.0

1 National => % 93.0 93.0 - Mar 2019 - 89.5 96.5

1 National => % 96.0 96.0 - Mar 2019 94.3100.096.0 - 98.1 97.8

1 National => % 94.0 94.0 - Mar 2019 95.2 98.6

1 National => % 98.0 98.0 ##### - Mar 2019 - 100.0

1 National => % 94.0 94.0 - Mar 2019 - -

1 National => % 85.0 85.0 - Mar 2019 85.7 89.4 77.8 - 86.9 86.5

1 National => % 85.0 85.0 - Mar 2019 85.7 89.7 77.8 - 87.2 86.5

1 National => % 90.0 90.0 - Mar 2019 - 90.0 - - 90.0 93.9

1 National => % 90.0 90.0 - Mar 2019 82.6 95.2100.0 - 89.0 87.0

1 National No 12 9 13 9 6 6 17 8 10 11 8 8 11 11 11 9 12 - Mar 2019 2.5 6.0 3.0 0.0 11.5 118.0

1 National No 2 3.0 3.02.0 3.0 1.5 1.5 1.52.5 2.5 1.0 2.01.0 3.0 2.0 3.0 7.0 - Mar 2019 1.0 3.0 3.0 0.0 7.0 28.5

1 National No 173104102113280118104112113146 86 104101197137177209 - Mar 2019 163 175 209 0 209

1 National <= No 0.0 0.0 7 7 3 9 4 3 7 6 4 2 7 4 6 6 5 9 2 7 Apr 2019 7 - - - 7 7

National % 20 0 54 0 55 60 67 36 67 65 71 69 56 53 87 38 67 - Mar 2019 - - - - 67 63

PAGE 8 Year To

Date

2 weeks (Breast Symptomatic)

31 Day (diagnosis to treatment)

31 Day (second/subsequent treatment - surgery)

31 Day (second/subsequent treatment - drug)

31 Day (second/subsequent treat - radiotherapy)

62 Day (urgent GP referral to treatment) Excluding Rare Cancer

62 Day (referral to treat from screening)

62 Day (referral to treat from hosp specialist)

Cancer - Patients Waiting over 62 days

Cancer - Patients Waiting over 104 days

Cancer - Longest Waiter in days

IPT Referrals - Within 38 Days Of GP Referral for 62 day cancer pathway

Trend

Clinical Effectiveness - Cancer Care

Neutropenia Sepsis Door to Needle Time Greater Than 1 Hour 62 Day (urgent GP referral to treatment) Including Rare Cancer 2 weeks Data

Source Data Quality

PerfFrame

work Indicator Measure Trajectory Previous Months Trend (since Nov 2017) Data

Period

Group

Month

90 92 94 96 98 100

May 2017

Jun 2017

Jul 2017

Aug 2017

Sep 2017

Oct 2017

Nov 2017

Dec 2017

Jan 2018

Feb 2018

Mar 2018

Apr 2018

May 2018

Jun 2018

Jul 2018

Aug 2018

Sep 2018

Oct 2018

Nov 2018

Dec 2018

Jan 2019

Feb 2019

Mar 2019

Apr 2019

2-week wait from Referral to Date First Seen

Trust National Forecast Trajectory National Target 80

85 90 95 100

May 2017

Jun 2017

Jul 2017

Aug 2017

Sep 2017

Oct 2017

Nov 2017

Dec 2017

Jan 2018

Feb 2018

Mar 2018

Apr 2018

May 2018

Jun 2018

Jul 2018

Aug 2018

Sep 2018

Oct 2018

Nov 2018

Dec 2018

Jan 2019

Feb 2019

Mar 2019

Apr 2019

2-week wait from Breast Symptomatic Patients

Trust National Forecast Trajectory National Target

94 95 96 97 98 99 100

May 2017

Jun 2017

Jul 2017

Aug 2017

Sep 2017

Oct 2017

Nov 2017

Dec 2017

Jan 2018

Feb 2018

Mar 2018

Apr 2018

May 2018

Jun 2018

Jul 2018

Aug 2018

Sep 2018

Oct 2018

Nov 2018

Dec 2018

Jan 2019

Feb 2019

Mar 2019

Apr 2019

31-day Diagnosis to First Treatment

Trust National National Target

0 20 40 60 80 100 120

May 2017 Jun 2017 Jul 2017

Aug 2017 Sep 2017

Oct 2017

Nov 2017 Dec 2017

Jan 2018

Feb 2018

Mar 2018 Apr 2018

May 2018 Jun 2018 Jul 2018

Aug 2018 Sep 2018

Oct 2018

Nov 2018 Dec 2018

Jan 2019

Feb 2019

Mar 2019 Apr 2019

62-day Urgent GP Referral to First Treatment

Trust - Excl Rare Cancer Trust - Incl Rare Cancer National Forecast Trajectory National Target NHSI Improvement Trajectory

0 10 20 30 40 50 60 70 80 90

62-day Urgent GP Referral to First Treatment Breach- By Tumour Site

Upper GI Testicular Skin Lung Lower GI Head & Neck Heamatology Gynaecology Childrens Breast Urological

0 2 4 6 8 10 12 14 16 18

0 20 40 60 80 100 120

Patients

Performance (%)

62-day Urgent GP Referral to First Treatment

Number over 62 days Trust - Incl Rare Cancer National Performance National Standard 0

2 4 6 8 10 12

Neutropenia Sepsis Door to Needle Time Greater Than 1 Hour

Dummy Directorate General Surgery Scheduled Care/Long Term Conditions

Theatres Gynaecology, Gynae-Oncology and GUMAcute & Community Paediatrics Ambulatory Therapies Community Medicine

Referências

Documentos relacionados

O termo gramatical “onde”, nas gramáticas normativo-prescritivas de língua portuguesa, pode ser classificado, no plano paradigmático, como advérbio interrogativo (Onde você